Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; R factor = 0.021; wR factor = 0.048; data-to-parameter ratio = 13.5.
In the title compound, C 9 H 11 BrN 2 O 5 , the ribofuranose ring has a C2-exo, C3-endo twist configuration and is attached to the uracil unit via a -N 1 -glycosidic bond. The crystal structure is stabilized by two intermolecular O-HÁ Á ÁO interactions and one intermolecular N-HÁ Á ÁO interaction.
Related literature
For the synthesis of the title compound and its analogues, see: Shakya et al. (2010) . For a related structure, see: Suck et al. (1972) . For the use of the title compound as a pharmaceutical intermediate, see : Haraguchi et al. (1993) ; Kittaka et al. (1992) ; Pozharskii et al. (1997) ; Sairam et al. (2003) . For the biological activity of nucleoside derivatives, see: Johar et al. (2005) . Data collection: SMART (Bruker, 2008); cell refinement: SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) and DIAMOND (Brandenburg, 1999) ; software used to prepare material for publication: SHELXTL. 
Experimental

Comment
In the last few decades, there has been dramatic progress in the synthesis of the nucleoside analogues for their biological evaluation of the anticancer activity (Johar et al., 2005; Shakya et al., 2010; Suck et al., 1972) . The title compound (I) can be used as important pharmaceutical intermediates (Haraguchi et al., 1993; Kittaka et al., 1992; Pozharskii et al., 1997; Sairam et al., 2003) . The synthetic procedure is described below. To know the relative stereochemistry of the anomeric position in the ribofuranose ring, it is necessary to gain the well defined structure of (I) by X-diffraction method. The molecular structure of the title compound is shown in Fig. 1 . From the single-crystal structure we observed that the ribofuranose ring has a C2-exo, C3-endo twist configuration and the anomeric carbons are always β configuration in the crystal packing. The crystal structure of (I) is stabilized by two intermolecular O-H···O interactions and one intermolecular N-H···O interaction ( 
Experimental
All reagents and solvents were used as obtained commercially without further purification. NMR spectra was recorded on Bruker AV 400 MHz NMR spectrometers at ambient temperature. The title compound was prepared according to the reported procedure (Shakya et al., 2010) . Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) 0.0332 (9) 0.0331 (9) 0.0208 (7) −0.0096 (9) 0.0003 (9) 0.0002 (6) O2 0.0309 (11) 0.0294 (9) 0.0879 (14) −0.0012 (10) 0.0003 (11) 0.0049 (9) O3 0.0382 (10) 0.0327 (9) 0.0309 (9) 0.0040 (9) 0.0079 (8) −0.0120 (7) O4 0.0367 (10) 0.0306 (9) 0.0323 (9) 0.0106 (10) −0.0057 (9) 0.0008 (7) O5 0.0433 (11) 0.0416 (11) 0.0203 (8) 0.0005 (9) 0.0073 (8) 0.0001 (8) Geometric parameters (Å, °) 
